Oncology Investigational Drug Service (IDS) — Baltimore, Maryland

Oncology Investigational Drug Service (IDS) is a clinical research site located in Baltimore, Maryland, United States 21287.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Oncology Investigational Drug Service (IDS) has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma.

Sponsors: Pfizer.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Oncology Investigational Drug Service (IDS)?

Oncology Investigational Drug Service (IDS) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Oncology Investigational Drug Service (IDS) conducted?

Oncology Investigational Drug Service (IDS) has 1 clinical trials on record, with 1 currently active. Their work covers Cachexia, Metastatic Pancreatic Ductal Adenocarcinoma.

Is Oncology Investigational Drug Service (IDS) accredited by Crixeo Health?

Oncology Investigational Drug Service (IDS) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Oncology Investigational Drug Service (IDS)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.